Jasmin Hundal: Exploring How Treatment Reshapes Tumor Biology in HR+ Breast Cancer
Jasmin Hundal: Exploring How Treatment Reshapes Tumor Biology in HR+ Breast Cancer Oncodaily
Онкология
🎗️Лента новостей
Онкология
Michelle Mitchell։ Cancer Research UK Calls for Cancer to Be a Priority in Northern Ireland
Michelle Mitchell։ Cancer Research UK Calls for Cancer to Be a Priority in Northern Ireland Oncodaily
Онкология
Protein linked to cell death may also drive liver cancer
New research from the University of Oklahoma identifies a protein in liver cells that appears to help drive the development of liver cancer associated with obesity-related fatty liver disease. The finding, published in Hepatology, points to the protein as a potential new therapeutic target for liver cancer.
Онкология
$10M histotripsy research center launches to advance sound wave-based cancer treatment | Newswise
$10M histotripsy research center launches to advance sound wave-based cancer treatment | Newswise Newswise
🎗️
Онкология
Radical radiotherapy use rising for treating lung cancer
Radical radiotherapy use rising for treating lung cancer AuntMinnie
Онкология
Making Treatment Decisions in Advanced Prostate Cancer
Making Treatment Decisions in Advanced Prostate Cancer medpagetoday.com
🎗️
Онкология
How I Became a Global Oncology Leader
How I Became a Global Oncology Leader ASCO Connection
🎗️
Онкология
FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer
FDA Clears Clinical Trial Using CAR T-Cells to Fight Colorectal Cancer University of Colorado Anschutz
Онкология
Novel immunotherapy leads to complete regression of chemotherapy-resistant liver cancer in 3-year-old
A new report in the New England Journal of Medicine by researchers at Baylor College of Medicine, Texas Children's Hospital and Seattle Children's describes a complete regression of hepatoblastoma, the most common pediatric liver cancer, in a 3-year-old treated with a novel immunotherapy.
Онкология
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer PR Newswire
Онкология
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer Yahoo Finance Singapore
Онкология
Vepdegestrant Opens the PROTAC Era in Breast Cancer: Why Induced Proximity Matters Beyond ESR1
Vepdegestrant Opens the PROTAC Era in Breast Cancer: Why Induced Proximity Matters Beyond ESR1 Oncodaily
Онкология
Причины необычной заболеваемости раком будут искать в провинции Канады
Причины необычной заболеваемости раком будут искать в провинции Канады vancouverok.com
Онкология
25 years after 9/11, lessons emerge for long-term care
Twenty-five years after the Sept. 11 terrorist attacks, long-term follow-up of people exposed to the disaster offers important lessons for managing chronic disease in disaster-exposed populations, according to a review published in JAMA. The review is based on data from the World Trade Center (WTC) Health Program…